About
ST PHARM is a family company of the Dong-A Sosio Group, which has a history of 80 years in the domestic market . It produces excellent APIs with the mission of 'endless challenge for human health and happiness' I want to. The company is pursuing contract development and manufacturing (CDMO) projects that involve research and development with global pharmaceutical companies, beyond simple consignment production. Through accumulated research and technological expertise, They supply raw material pharmaceuticals to domestic and overseas pharmaceutical companies. In addition, through active investment and system construction, they are operating an international quality and production system certified by cGMP from regulatory agencies such as US FDA, EMA, as well as MFDS in Korea. In the meantime, as a result of constant investment and technological development, the company has been selected as an Advanced Technology Center (ATC), an innovative pharmaceutical company, and a World Class 300
Investment Focus
- Location
- Seoul, South Korea
Contact Information
Find more investors like ST
Search Investors